Skip to Content

GLIBENCLAMIDE 2.5 MG TABLETS

Active substance(s): GLIBENCLAMIDE / GLIBENCLAMIDE / GLIBENCLAMIDE

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

PC 3069

MEDREICH LIMITED
Product Customer Reason for Issue Layout No. Item Code

Title: Art Work Approval Form
Glibenclamide - S/L - English - PIL MEDREICH PLC New PIF NA XXXXXXXX (WOA)
Check for all aspects Colours: Dimensions: No. of Folds Specification: Printed on 56 - 60 GSM Maplitho paper

Single - Black

280 x 240 mm (Open size), 140 x 30 mm (Folded size) 4 Artwork No.:
100% check on text matter:

Artwork made to NA
Check on design and adequacy of text matter: Dimensions & Colour Shade: Confirmed by PDC Check on Dimensions & OPD aspects:

75%

Check on Label claim, License, Codes aspects:

PDC

Regulatory :

IBD:

Technical services:

QC:
WIN\\192.168.1.32\pdc\Artworks\Medreich\UK Products\Glibenclamide\Tablets\PIL\Glibenclamide SL English PIL_22.09.11.ai MED/GLI/PIL/03 Internal Approval issued on CD issued on Format No.: CO-QA005-F06-00

CQA:
27(RK)/28.10.10(MA)/ 22.09.11(MA)

PL 21880/0113 PL 21880/0114

This leaflet was last approved in {08/2011}.

Marketing Authorisation Holder and Manufacturer Medreich Plc, 9 Royal Parade Kew Gardens Surrey TW9 3QD United Kingdom

XXXXXXX

MEDREICH LIMITED
Product Customer Reason for Issue Layout No. Item Code

Title: Art Work Approval Form
Glibenclamide - S/L - English - PIL MEDREICH PLC New PIF NA XXXXXXXX (WOA)
Check for all aspects Colours: Dimensions: No. of Folds Specification: Printed on 56 - 60 GSM Maplitho paper

Single - Black

280 x 240 mm (Open size), 140 x 30 mm (Folded size) 4 Artwork No.:
100% check on text matter:

Artwork made to NA
Check on design and adequacy of text matter: Dimensions & Colour Shade: Confirmed by PDC Check on Dimensions & OPD aspects:

75%

Check on Label claim, License, Codes aspects:

PDC

Regulatory :

IBD:

Technical services:

QC:
WIN\\192.168.1.32\pdc\Artworks\Medreich\UK Products\Glibenclamide\Tablets\PIL\Glibenclamide SL English PIL_22.09.11.ai MED/GLI/PIL/03 Internal Approval issued on CD issued on Format No.: CO-QA005-F06-00

CQA:
27(RK)/28.10.10(MA)/ 22.09.11(MA)

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide